In silico prediction of immunogenic T cell epitopes for HLA-DQ8

Javed Mohammed Khan, Gaurav Kumar, Shoba Ranganathan*

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Citations (Scopus)
14 Downloads (Pure)


Background: HLA-DQ alleles are involved in the pathogenesis of hypersensitivity reactions and autoimmune disorders, with HLA-DQ8 associated with several human autoimmune disorders. Limited success has been achieved using sequence-based computational techniques for predicting HLA-DQ8-restricted T cell epitopes while accuracy and efficiency of recently developed structure-based models need to be improved. Results: We describe a combined structure-based prediction approach for DQ8-restricted T cell epitope prediction using a recently developed fast and accurate docking protocol, pDOCK, and molecular surface electrostatic potential (MSEP)-based clustering of pMHC binding interfaces. The prediction model was rigorously trained, tested and validated using experimentally verified DQ8 binding and non-binding peptides. High MHC-binding prediction accuracy is validated against independent experimental data (average area under the ROC curve or average A ROC>0.94). Our model also predicts all binding registers correctly and known T cell activators with a positive predictive value (PPV) of 0.91 or 91%. We also studied the binding patterns of DQ8-binding peptides and confirm the existence of peptide epitopes that do not conform to DQ8-specific consensus peptide-binding motifs. Conclusions: We have developed a model that can be successfully applied as a generic protocol for easy in silico identification of HLA-DQ8 binding peptides and thereby potential DQ8-specific T cell epitopes. The current model is therefore applicable for screening potential vaccine candidates from DQ8 binding peptides irrespective of consensus peptide-binding or sequence motifs. We have also illustrated efficient discrimination of different categories of binders from non-binders as well as different categories of pMHC agonists from non-agonists, while accurately predicting the binding registers of DQ8-restricted peptides. This combined approach provides a set of sensitive and specific computational tools to facilitate high-throughput screening of peptides for immunotherapeutic applications such as controlling allergic and autoimmune responses.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalImmunome Research
Issue number1
Publication statusPublished - 2012

Bibliographical note

This version is archived for private and non-commercial use under the terms of this BioMed Central open access license ("license") (see The work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. For further rights please check the terms of the license, or contact the publisher.

Fingerprint Dive into the research topics of 'In silico prediction of immunogenic T cell epitopes for HLA-DQ8'. Together they form a unique fingerprint.

Cite this